HIV prevention drug hailed as breakthrough, but who gets access?

• A medicine injected just twice a year could transform the fight against HIV.
• In a 2024 clinical trial involving more than 2,000 young women in South Africa and Uganda, no participants who received lenacapavir contracted HIV.